✦ LIBER ✦

Development of nephrotic syndrome in a patient with acute myeloblastic leukemia after treatment with macrophage—Colony-stimulating factor

✍ Scribed by Kayoko Omura; Tetsuya Kawamura; Yasunori Utsunomiya; Aya Abe; Kensuke Joh; Osamu Sakai

Book ID: 117443753
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 990 KB
Volume: 27
Category: Article
ISSN: 0272-6386
DOI: 10.1016/s0272-6386(96)90527-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of a 93-year-old pa

Successful treatment of a 93-year-old patient with hypoplastic acute monocytic leukemia using macrophage colony-stimulating factor

✍ Ayako Watanabe; Yasunori Kawachi; Yukihiro Sakamoto; Kimiko Ishikawa; Toshio Nis 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 744 KB

Successful use of granulocyte-macrophage

Successful use of granulocyte-macrophage colony-stimulating factor in patients with acute lymphocytic leukemia

✍ Howard Grossberg 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Development of Kawasaki syndrome in auto

Development of Kawasaki syndrome in autoimmune neutropenia after treatment with granulocyte colony-stimulating factor

✍ Kentaro Ueno; Yuichi Nomura; Michiko Arata; Shinsuke Maruyama; Takayuki Tanabe; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Granulocyte-Macrophage colony stimulatin

Granulocyte-Macrophage colony stimulating factor (GM-CSF) priming in the treatment of elderly patients with acute myelogenous leukemia

✍ Paul S. Frenette; Jane F. Desforges; David P. Schenkein; Arthur Rabson; Christop 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 783 KB

Therapy-related acute myeloblastic leuke

✍ Valković, T.; Seili-Bekafigo, I.; Bašić-Kinda, S.; Labar, B.; Duletić-Načinović, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 760 KB

Treatment of de novo acute myelogenous l

Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: Effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts

✍ Valent, Peter ;Sillaber, Christian ;Geissler, Klaus ;Andreeff, Michael ;Tafuri, 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

GM-CSF is a major regulator of myelopoiesis. Recombinant human GM-CSF (250 micrograms/m2 per day i.v.) was used prior to chemotherapy ("3 + 7" scheme) to recruit leukemic blasts in vivo (de novo AML patients, n = 20) into the chemotherapy sensitive phases of the cell cycle. The stimulatory effect of